Major Pharma Adopts Digital Twin Platform

- The global digital twin market in healthcare and pharmaceuticals is projected to grow from $1.17 billion in 2022 to $38.43 billion by 2032, expanding at a compound annual growth rate (CAGR) of 42.2%. This growth is driven by the technology's ability to reduce R&D timelines and optimize manufacturing operations. - Digital twins are being used in process development to simulate and predict the impact of varying parameters—such as media composition or temperature—on cell growth and product yield without costly physical experiments. In process validation, they can reduce the number of required Process Performance Qualification (PPQ) runs, saving significant costs. - A primary challenge to enterprise-wide adoption is the integration of data from disparate sources, including Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), and Enterprise Resource Planning (ERP) systems. Creating a unified and traceable view of manufacturing performance is a critical prerequisite for a functional digital twin. - Machine learning and AI are integral to digital twin platforms, enabling predictive capabilities for identifying optimal process conditions and anticipating equipment failures or process deviations before they occur. These "soft sensors" can infer critical quality attributes in real-time from simpler data points like pH and dissolved oxygen, reducing the need for time-consuming offline assays. - Pfizer utilized digital twin technology to accelerate the scale-up of its biologic antibody production processes, using computational fluid dynamics (CFD) to model mass transfer in bioreactors and minimize required experimental studies. Other companies like Sanofi have implemented digital twins to simulate process changes *in silico* before applying them to their physical manufacturing lines. - In GMP environments, digital twins enhance compliance by creating a validated, audit-ready foundation for continuous process verification and rapid batch release. They ensure data integrity and traceability by automatically capturing data in real-time, aligning with principles like ALCOA+. - Key technology providers in the life sciences digital twin space include Siemens, Dassault Systèmes with its 3DEXPERIENCE platform, and Microsoft with its Azure Digital Twins platform-as-a-service offering. These platforms provide the infrastructure for integrating IoT data, running simulations, and managing the entire product lifecycle.